Granite Point Capital Management’s Avenue Therapeutics, Inc. Common Stock ATXI Stock Holding History

Granite Point Capital Management’s Portfolio ATXI Stock Details ATXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-15	Closed	-$49K	–	132
2018 Q3	$49K	Hold	15	–	–	﹤0.01%	116
2018 Q2	$61K	Buy	+15	New	+$69.6K	0.01%	117

Other funds holding ATXI

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

FWM

Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Granite Point Capital Management's ATXI Position: Q4 2018 in Review

Granite Point Capital Management sold out of Avenue Therapeutics, Inc. Common Stock (ATXI) in Q4 2018, closing a stake of 15 shares — an estimated $49K sold.

Granite Point Capital Management first reported a position in ATXI in Q2 2018 and held it in 2 quarters. The position peaked at $61K in Q2 2018. 7 funds tracked by Wall St. Rank hold ATXI as of Q4 2018.

Granite Point Capital Management reported no remaining Avenue Therapeutics, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Granite Point Capital Management sold 15 Avenue Therapeutics, Inc. Common Stock shares in Q4 2018, an estimated $49K.
Granite Point Capital Management first reported a position in Avenue Therapeutics, Inc. Common Stock in Q2 2018 and held it in 2 quarters.
Granite Point Capital Management's Avenue Therapeutics, Inc. Common Stock position peaked at $61K in Q2 2018.
7 funds tracked by Wall St. Rank held Avenue Therapeutics, Inc. Common Stock as of Q4 2018.

Based on Granite Point Capital Management's 13F filing for Q4 2018, filed 5 Feb 2019.